Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist
Thomas Thum(Medizinische Hochschule Hannover), Johann Bauersachs(Medizinische Hochschule Hannover), Paolo Galuppo, Stefan Engelhardt(Heidelberg University), Jan Fiedler(Medizinische Hochschule Hannover), Kai Hu(Jiangsu University), S. Frantz, G. Ertl, Coleman Gross
Cited by 1
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888